PIBAX
Price
$19.38
Change
-$0.20 (-1.02%)
Updated
Nov 13 closing price
Net Assets
1.06B
RLBGX
Price
$39.11
Change
-$0.48 (-1.21%)
Updated
Nov 13 closing price
Net Assets
268.67B
Interact to see
Advertisement

PIBAX vs RLBGX

Header iconPIBAX vs RLBGX Comparison
Open Charts PIBAX vs RLBGXBanner chart's image
PGIM Balanced A
Price$19.38
Change-$0.20 (-1.02%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R6
Price$39.11
Change-$0.48 (-1.21%)
VolumeN/A
Net Assets268.67B
PIBAX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
PIBAX vs. RLBGX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIBAX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 269B vs. PIBAX (1.06B). RLBGX (2.01) and PIBAX (1.94) have matching dividends . PIBAX was incepted earlier than RLBGX: PIBAX (29 years) vs RLBGX (17 years). PIBAX (1.12) is less costly to investors than RLBGX (0.25). PIBAX is a more actively managed with annual turnover of: 107.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than PIBAX: RLBGX (250) vs PIBAX (1000). RLBGX annual gain was more profitable for investors over the last year : 9.13 vs. PIBAX (6.44). RLBGX return over 5 years is better than : 41.63 vs. PIBAX (26.40).
PIBAXRLBGXPIBAX / RLBGX
Total Expense Ratio1.000.25400%
Annual Report Gross Expense Ratio1.120.25448%
Fund Existence29 years17 years-
Gain YTD13.51315.15789%
Front Load3%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends1.942.0197%
Returns for 1 year6.449.1371%
Returns for 3 years40.8343.9893%
Returns for 5 years26.4041.6363%
Returns for 10 years46.8577.9060%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX74.621.30
+1.77%
Inhibrx Biosciences Inc.
PRQR2.16N/A
N/A
ProQR Therapeutics NV
INFY16.96-0.13
-0.76%
Infosys Limited
OZK43.98-1.00
-2.22%
Bank OZK
PASG8.53-0.85
-9.06%
Passage Bio Inc